Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Breast Cancer Research
Published in: Breast Cancer Research 3/2003

01-06-2003 | Editorial

Introducing Viewpoints – Breast Cancer Research'snew style literature appraisal service

Author: Valerie Speirs

Published in: Breast Cancer Research | Issue 3/2003

Login to get access

Abstract

Literature awareness is an essential requirement for successful research. Breast Cancer Research has launched a new Viewpoints section, which replaces the Paper Reports section as a means of highlighting important research articles relevant to the biology of breast cancer and bringing them to the attention of the breast cancer community.
Literature
1.
Waterworth A: New insights into the biological function of BRCA2 from its structural interactions. Breast Cancer Res. 2003, 5: 107-108. 10.1186/bcr581.CrossRefPubMedPubMedCentral
2.
Schmeichel KL: Centrosome cycle studies reveal promising candidates for anti-cancer drug design. Breast Cancer Res. 2003, 5: 59-10.1186/bcr564.CrossRefPubMed
3.
Clarke RB: Mutations in DNA damage response genes and breast cancer susceptibility. Breast Cancer Res. 2002, 4: 253-10.1186/bcr458.CrossRef
4.
5.
Metadata
Title
Introducing Viewpoints – Breast Cancer Research'snew style literature appraisal service
Author
Valerie Speirs
Publication date
01-06-2003
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue 3/2003
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr600

Other articles of this Issue 3/2003

Breast Cancer Research 3/2003 Go to the issue

Commentary

The future of cytotoxic therapy: selective cytotoxicity based on biology is the key

Review

Host microenvironment in breast cancer development: Extracellular matrix–stromal cell contribution to neoplastic phenotype of epithelial cells in the breast

Research article

Adolescent diet and risk of breast cancer

Viewpoint

p27KIP1phosphorylation by PKB/Akt leads to poor breast cancer prognosis

Review

Breast cancer-induced angiogenesis: multiple mechanisms and the role of the microenvironment

Review

Inflammatory breast cancer: Relationship between growth factor signaling and motility in aggressive cancers
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits